FIELD: pharmaceutical industry. SUBSTANCE: described are 2-aminoindane analogs of general formula I: 
wherein R1 and R2 are independently hydrogen, C1-C8 alkyl; X is CH2R3 or NHSO2R4;y is hydrogen, NHSO2R4,SO2(Ph); R3 is NHSO2R4,SO2R4,CONR1R2; R4 is C1-C8 alkyl, phenyl or phenyl substituted by CN or -CF3 and pharmaceutically acceptable salts thereof which show activity with respect to Dopamine receptors. EFFECT: new 2-aminoindanes. 8 cl, 5 dwg, 40 ex, 1 tbl
